Besides fundamental function of HDL, that is reverse cholesterol transport, recent clinical and epidemiologic studies have uncovered novel HDL’s functions. These novel HDL’s functions are not confined to cardioprotective role but, encompass non-cardiovascular pathologies. In this session, four outstanding speakers will discuss the non-cardiovascular role of HDL from a clinical viewpoint. Professor Alicia Jenkins from University of Melbourne, Australia, will talk about the modulation of glucose metabolism with HDL and HDL-targeted therapy in diabetes. Second speaker, Professor Maciej Banach from Medical University of Lodz, Poland, will talk about the association between HDLs, mild and extreme changes in plasma HDL cholesterol levels and cancer incidence and mortality. Third speaker, Professor Timothy Kwok from The Chinese University of Hong Kong, Hong Kong, will discuss the association between serum HDL cholesterol level and cognitive function and dementia. Last speaker, Professor Seung-Hwan Lee from the Catholic University of Korea, Korea, will talk about the association between serum HDL cholesterol level and cardiovascular disease and mortality from a nationwide cohort data in Korea.
International Lipid Expert Panel (ILEP) 2020 Guidelines on the Definition and Management With Statin Intolerance